Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity Hospital Ostrava

About this trial

This is a non-interventional study that will not pose any burden for the participants. The study subjects will be examined and treated in a standard manner according to current clinical recommendations for the treatment of overactive bladder (OAB). A portion of urine samples, which are routinely collected for biochemical and culture examinations as part of the diagnostic process, will be sent for examination of the characteristics of the urinary microbiome and metabolome (UMM) before and after treatment.

Eligibility criteria

Qualifiers

Adult women over 18 years of age

Written consent to participate in the study

Willingness to undergo OAB evaluation and treatment according to the protocol

OAB symptoms lasting longer than 3 months

Disqualifiers

Known congenital developmental defects of the urinary tract (congenital hydronephrosis, vesicoureteral reflux, renal agenesis and hypoplasia, multicystic and polycystic kidneys)

Any previous treatment for OAB

Recurrent urinary tract infections (more than 3 episodes in the last 12 months)

Presence of a foreign body in the urinary tract - urolithiasis, urinary catheter, ureteral stent

Trial design

Treatments tested in this trial

  • Urine Microbiological and Metabolomic Analysis

Treatment groups

80 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital Ostrava

Lead sponsor

University Hospital Bulovka

Collaborator

Thomayer University Hospital

Collaborator

Institute of Microbiology of the Czech Academy of Sciences

Collaborator